Micro-RNA Expression Profiles in Localised Prostate Cancer

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03338712

Enrollment

Registered

2017-11-09

Start date

2010-02-01

Completion date

2016-04-01

Last updated

2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer, Radical Prostatectomy

Brief summary

Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

35 Years to 80 Years

Inclusion criteria

* 35 Years to 80 Years * Male * Patients with clinically localised high risk prostate cancer

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Recurrence free survival	Up to 120 months. From date of inclusion until date of death from any cause	The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association.

Secondary

Measure	Time frame	Description
Cancer specific survival	Up to 120 months. From date of inclusion until date of death from any cause	Cancer specific survival

Outcome results